A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH TERIFLUNOMIDE IN ADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
Details
Age
Adult
Type of Study
Treatment
Locations
Brain Imaging Center (BIC)
University of Colorado Hospital
Principal Investigator
Enrique Alvarez, MD, PhD
Study ID
Protocol Number: 20-2036
More information available at ClinicalTrials.gov: NCT04586010
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers